Multidisciplinary Care of Alcohol-related Liver Disease and Alcohol Use Disorder: A Narrative Review for Hepatology and Addiction Clinicians

被引:9
作者
Shroff, Hersh [1 ,3 ]
Gallagher, Heather [2 ]
机构
[1] Univ N Carolina, Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA
[2] Univ North Carolina Hosp, Subst Treatment & Recovery Program, Chapel Hill, NC USA
[3] Univ N Carolina, Burnett Womack Bldg,CB 7584, Chapel Hill, NC 27599 USA
关键词
Alcohol-related liver disease; Alcohol use disorder; Liver transplantation; Multidisciplinary; Integrated care; CHRONIC HEPATITIS-C; NATIONAL EPIDEMIOLOGIC SURVEY; RANDOMIZED CONTROLLED-TRIAL; ORAL NALTREXONE TREATMENT; DOUBLE-BLIND; LONG-TERM; FOLLOW-UP; CIRRHOSIS; TRANSPLANTATION; INTERVENTION;
D O I
10.1016/j.clinthera.2023.09.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: Models of integrated, multidisciplinary care are optimal in the setting of complex, chronic diseases and in the overlap of medical and mental health disease, both of which apply to alcohol-related liver disease (ALD). Alcohol use disorder (AUD) drives nearly all cases of ALD, and coexisting mental health disease is common. ALD is a complex condition with severe clinical manifestations and high mortality that can occasionally lead to liver transplantation. As a result, integrated care for ALD is an attractive proposition. The aim of this narrative review was to: (1) review the overlapping and concerning trends in the epidemiology of AUD and ALD; (2) use a theoretical framework for integrated care known as the "five-component model " as a basis to highlight the need for integrated care and the overlapping clinical manifestations and management of the 2 conditions; and (3) review the existing applications of integrated care in this area.Methods: We performed a narrative review of epidemiology, clinical manifestations, and management strategies in AUD and ALD, with a particular focus on areas of overlap that are pertinent to clinicians who manage each disease. Previously published models were reviewed for integrating care in AUD and ALD, both in the general ALD population and in the setting of liver transplantation.Findings: The incidences of AUD and ALD are rising, with a pronounced acceleration driven by the Coronavirus Disease 2019 pandemic. Hepatologists are underprepared to diagnose and treat AUD despite its high prevalence in patients with liver disease. A patient who presents with overlapping clinical manifestations of both AUD and ALD may not fit neatly into typical treatment paradigms for each individual disease but rather will require new management strategies that are appropriately adapted. As a result, the dimensions of integrated care, including collective ownership of shared goals, interdependence among providers, flexibility of roles, and newly created professional activities, are highly pertinent to the holistic management of both diseases.Implications: Integrated care models have proliferated as recognition grows of the dual pathology of AUD and ALD. Ongoing coordination across disciplines and research in the fields of hepatology and addiction medicine are needed to further elucidate optimal mechanisms for collaboration and improved quality of care.
引用
收藏
页码:1177 / 1188
页数:12
相关论文
共 101 条
[1]   Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study [J].
Addolorato, Giovanni ;
Leggio, Lorenzo ;
Ferrulli, Anna ;
Cardone, Silvia ;
Vonghia, Luisa ;
Mirijello, Antonio ;
Abenavoli, Ludovico ;
D'Angelo, Cristina ;
Caputo, Fabio ;
Zambon, Antonella ;
Haber, Paul S. ;
Gasbarrini, Giovanni .
LANCET, 2007, 370 (9603) :1915-1922
[2]   Liver Transplantation in Alcoholic Patients: Impact of an Alcohol Addiction Unit Within a Liver Transplant Center [J].
Addolorato, Giovanni ;
Mirijello, Antonio ;
Leggio, Lorenzo ;
Ferrulli, Anna ;
D'Angelo, Cristina ;
Vassallo, Gabriele ;
Cossari, Anthony ;
Gasbarrini, Giovanni ;
Landolfi, Raffaele ;
Agnes, Salvatore ;
Gasbarrini, Antonio .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2013, 37 (09) :1601-1608
[3]  
American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders, V4th ed., DOI [DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]
[4]   Prevalence of alcohol-associated liver disease: a systematic review and meta-analysis [J].
Amonker, Sachin ;
Houshmand, Aryo ;
Hinkson, Alexander ;
Rowe, Ian ;
Parker, Richard .
HEPATOLOGY COMMUNICATIONS, 2023, 7 (05)
[5]  
[Anonymous], 1993, Alcohol Clin Exp Res, V17, P1130
[6]  
[Anonymous], 2013, The ASAM criteria: Treatment criteria for addictive, substance-related and co-occurring conditions, V3rd
[7]  
[Anonymous], 1997, Managing Managed Care: Quality Improvement in Behavioral Health, P5477, DOI [10.17226/5477, DOI 10.17226/5477]
[8]   Combined pharmacotherapies and behavioral interventions for alcohol dependence - The COMBINE study: A randomized controlled trial [J].
Anton, RF ;
O'Malley, SS ;
Ciraulo, DA ;
Cisler, RA ;
Couper, D ;
Donovan, DM ;
Gastfriend, DR ;
Hosking, JD ;
Johnson, BA ;
LoCastro, JS ;
Longabaugh, R ;
Mason, BJ ;
Mattson, ME ;
Miller, WR ;
Pettinati, HM ;
Randall, CL ;
Swift, R ;
Weiss, RD ;
Williams, LD ;
Zweben, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (17) :2003-2017
[9]   The multidisciplinary support in preventing alcohol relapse after liver transplantation: A single-center experience [J].
Attilia, Maria Luisa ;
Lattanzi, Barbara ;
Ledda, Roberta ;
Galli, Anna Maria ;
Farcomeni, Alessio ;
Rotondo, Claudia ;
Di Gregorio, Vincenza ;
Mennini, Gianluca ;
Poli, Edoardo ;
Attilia, Fabio ;
Corradini, Stefano Ginanni ;
Rossi, Massimo ;
Merli, Manuela .
CLINICAL TRANSPLANTATION, 2018, 32 (05)
[10]  
Babor Thomas F, 2007, Subst Abus, V28, P7, DOI 10.1300/J465v28n03_03